Exclusive Interview with FoliuMed Founder and CEO Oliver Zugel When FoliuMed Founder and CEO Oliver Zugel spoke with New Cannabis Ventures in 2021, the company was just making initial...
Flora Growth Completes Acquisition of Category Leading Wellness Brand JustCBD; Enhances U.S. Infrastructure and CPG Portfolio JustCBD is an established CPG brand with a portfolio of over 300 products and a...
Flora Growth Announces Pricing of $30 Million Public Offering MIAMI & TORONTO-November 19, 2021-(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer...
Flora Growth Signs Definitive Agreement to Acquire Vessel Brand, Entering US Cannabis Consumer Technology Market & Strengthening Management Team Vessel, a leader in the luxury cannabis consumer technology market,...
Flora Growth Corp. Announces Pricing of Initial Public Offering TORONTO, May 11, 2021 (GLOBE NEWSWIRE) — Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), an all-outdoor cultivator and...
Exclusive Interview with FoliuMed Holdings Founder and CEO Oliver Zugel FoliuMed Holdings is a low-cost producer of medical cannabis with operations in Colombia and Germany and export relationships in...
Canopy Growth Announces Changes to Global Operations to Drive Strategic Focus These actions will further align global supply and demand and streamline operations Company continues to expect to incur...
TORONTO, September 11, 2019–(BUSINESS WIRE)–Vinzan International, Inc. is pleased to announce the 51% acquisition of Colombia Dreams Marihuana Inc. (“Colombia Dreams Marihuana” or “CDM”). Colombia Dreams Marihuana’s operations will...
Company enters multi-year agreement with Columbia-based Procaps to conduct advanced manufacturing in Latin America Spectrum Therapeutics receives new licences, certifications, and sales in international jurisdictions to advance Canopy Growth’s global...
– Acquisition will provide Company with international licenses and IP for cultivation, manufacturing, extraction, exportation, and R&D – Deal marks Company’s third pending M&A transaction this month as Medicine...
Acquisition will add extensive on-shelf product portfolio available in multiple regions Expands PharmaCielo’s global sales reach and market presence in Canada, Switzerland, Europe, Australia, New Zealand, Israel, and Brazil...
Clever Leaves First Colombian Company to Export Medical Cannabis to Canada Health Canada has authorized Clever Leaves to import dry cannabis flower for scientific purposes Bogotá, Colombia, February 7,...
PharmaCielo Announces TSX Venture Listing and Provides Corporate Update PharmaCielo to begin trading on the TSX Venture Exchange (“TSXV” or “TSX Venture”) under the Ticker PCLO on or about...
Aphria Unequivocally Stands Behind its LATAM Operations Assets Well Positioned to Create Substantial Value for Shareholders Executive Management Demonstrates Belief in Company Through $3.1M Acquisition of Shares on December 3, 2018 LEAMINGTON,...
Wayland Group Enters into Agreement to Expand Global Footprint with Acquisition in Colombia TORONTO, Nov. 06, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the...
LaSanta Botanicals Announces Closing of $6.4 Million Financing CALGARY, Alberta, Oct. 03, 2018 (GLOBE NEWSWIRE) — LaSanta Botanicals Ltd. (the “Company” or “LaSanta“) is pleased to announce that it...
Aphria Closes Acquisition of Assets in Latin America and the Carribean Company cements foothold in the region with operations in Colombia, Argentina and Jamaica LEAMINGTON, ON, Sept. 27, 2018...
Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN,...
Cronos Group Inc. Unveils Platform in LATAM TORONTO, Aug. 29, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ : CRON ) (TSX: CRON) (“Cronos Group” or the “Company”), is pleased to announce that it has entered...
Khiron Announces Pricing of Marketed Short Form Prospectus Offering of Common Shares TORONTO, Aug. 23, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ,...
PharmaCielo Closes Subscription Receipt Financings in Two Tranches for Gross Proceeds of over $39 Million; Provides Corporate Update Harvest of ~200,000 CBD-dominant plants and production of cannabis oil extracts...
Aurora Cannabis International Operational Update: Company Ships Mother Plants to Denmark to Populate Aurora Nordic Phase I MedReleaf Markham Facility now Fully EU GMP Certified EDMONTON, Aug. 13, 2018...
Khiron Signs Letter of Intent to Acquire Colombia’s Leading Health Network Acquisition to deliver network of 100,000 patients that meet Khiron’s indicated targets TORONTO, Aug. 7, 2018 /CNW/ –...
Exclusive Interview with Emblem President and CEO Nick Dean Emblem has signed a letter of intent to acquire Ontario-based licensed producer Natura Naturals, and President and CEO Nick Dean...
Increased capacity to meet market demand and advance the Company’s objective of addressing the medical needs of 1 million patients in Latin America TORONTO, Aug. 2, 2018 /CNW/ – Khiron Life Sciences Corp....
